TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Qyuns Therapeutics Co., Ltd. Class H ( (HK:2509) ) is now available.
Qyuns Therapeutics Co., Ltd. has entered into a Placing Agreement to issue 5,000,000 new H Shares at HK$20.0 per share, representing approximately 2.25% of the company’s issued shares. The shares will be placed with TruMed Health Innovation Fund LP, a healthcare-focused investment fund. The placement is expected to raise gross proceeds of approximately HK$100.0 million, with net proceeds earmarked for strategic allocation. The transaction is conducted under a General Mandate, and no additional shareholder approval is required.
More about Qyuns Therapeutics Co., Ltd. Class H
Qyuns Therapeutics Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the healthcare sector. The company focuses on the development and commercialization of therapeutic products, with a market focus on healthcare equities.
Average Trading Volume: 383,043
Technical Sentiment Signal: Strong Buy
See more insights into 2509 stock on TipRanks’ Stock Analysis page.